MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026)

MindWalk Holdings (HYFT) reported Liabilities and Shareholders Equity of $16.6 million for Q1 2026, down 48.36% year-over-year from $32.1 million in Q1 2025, and down 11.97% quarter-over-quarter from $18.8 million in Q4 2025.

MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $16.6 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $16.6 million, down 48.36% year-over-year; the trailing twelve-month figure through Jan 2026 was $96.3 million (down 41.13% YoY), and the FY2025 annual result was $31.9 million, down 27.89% from the prior year.
  • Liabilities and Shareholders Equity fell to $16.6 million in Q1 2026 per HYFT's latest filing, from $18.8 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $73.9 million in Q2 2022 and troughed at $16.6 million in Q1 2026.
  • A 5-year average of $46.6 million and a median of $44.6 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity surged 39.02% in 2022, then plunged 57.15% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $62.3 million in 2022, then dropped by 10.5% to $55.8 million in 2023, then retreated by 21.25% to $43.9 million in 2024, then sank by 57.15% to $18.8 million in 2025, then fell by 11.97% to $16.6 million in 2026.
  • Business Quant data shows HYFT's Liabilities and Shareholders Equity at $16.6 million in Q1 2026, $18.8 million in Q4 2025, and $29.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 37.37 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 811.27 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 14.93 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 33.89 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 23.64 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 26.48 Bn
9 Abivax 94.26 Bn 94.26 Bn - 640.56 Mn
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78 16.56 Mn

Historic Data

Download Data
DateValue
Jan 31, 2026 16.56 Mn
Oct 31, 2025 18.82 Mn
Jul 31, 2025 29.66 Mn
Apr 30, 2025 31.23 Mn
Jan 31, 2025 32.08 Mn
Oct 31, 2024 43.91 Mn
Jul 31, 2024 43.31 Mn
Apr 30, 2024 44.24 Mn
Jan 31, 2024 58.21 Mn
Oct 31, 2023 55.76 Mn
Jul 31, 2023 57.38 Mn
Apr 30, 2023 57.51 Mn
Jan 31, 2023 61.12 Mn
Oct 31, 2022 62.31 Mn
Jul 31, 2022 62.16 Mn
Apr 30, 2022 73.94 Mn
Jan 31, 2022 44.60 Mn
Oct 31, 2021 47.99 Mn
Jul 31, 2021 52.45 Mn
Apr 30, 2021 53.19 Mn